E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 3/3/2022 in the Prospect News Convertibles Daily.

New Issue: Innoviva prices upsized $225 million six-year convertibles to yield 2.125%, up 35%

By Abigail W. Adams

Portland, Me., March 3 – Innoviva Inc. priced an upsized $225 million of six-year convertible notes after the market close on Wednesday at par at the rich end of talk with a coupon of 2.125% and an initial conversion premium of 35%, according to a company news release and a market source.

Price talk was for a coupon of 2.125% to 2.625% and an initial conversion premium of 30% to 35%.

Goldman Sachs & Co. LLC and Moelis & Co. are bookrunners for the Rule 144A offering, which carries an upsized greenshoe of $45 million.

The initial size of the offering was $200 million with a greenshoe of $40 million.

The notes are non-callable until March 20, 2025 and then subject to a 130% hurdle.

They are putable upon a fundamental change. There is dividend protection.

Concurrently with the offering, the company will repurchase $144.8 million of its 2.125% convertible notes due 2023 for $165.6 million in privately negotiated transactions.

In connection with the offering, the company entered into capped call transactions with a cap price of $33.9850, representing a 75% premium over the last reported price of stock.

Net proceeds are expected to be $216.8 million or will be $260.5 million if the greenshoe is exercised in full.

Approximately $18.1 million will be used to cover the cost of the call spread and $144.8 million will be used to repurchase the 2023 notes with any remaining proceeds to be used for general corporate purposes.

Innoviva is a Burlingame, Calif.-based biopharmaceutical company.

Issuer:Innoviva Inc.
Amount:$225 million
Greenshoe:$45 million
Issue:Convertible senior notes
Maturity:March 15, 2028
Bookrunners:Goldman Sachs & Co. LLC and Moelis & Co.
Coupon:2.125%
Price:Par
Yield:2.125%
Conversion premium:35%
Conversion price:$26.22
Conversion rate:38.1432
Call options:Non-callable until March 20, 2025 and then subject to a 130% hurdle
Put options:Upon a fundamental change
Pricing date:March 2
Settlement date:March 7
Distribution:Rule 144A
Talk:Coupon of 2.125% to 2.625% and initial conversion premium of 30% to 35%
Stock symbol:Nasdaq: INVA
Stock price:$19.42 at market close March 2
Market capitalization:$1.35 billion

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.